Table 3.
Diagnosis | • Patient Concerns Inventory-Diagnosis41 |
• Satisfaction with Cancer Information profile (SCIP)40 | |
Treatment | • Hospital Anxiety Depression Scale (HADS)83 |
• Symptom Severity Scale (SSS)84 | |
• Visual Analog Scale (VAS)85 | |
Acute toxicity | • Late Effects in Normal Tissue (LENT)86/Subjective-Objective-Management-Analytic (SOMA)49 |
• Common Terminology Criteria for Adverse Events (CTC-AE)87 | |
• Oral Mucositis Weekly Questionnaire-Head and Neck Cancer (OMWQ-HN)88 | |
Early recovery | • EuroQOL EQ-5D-5L89 |
• European Organization for Research and Treatment of Cancer (EORTC) QLC-C3090 and EORTC H&N 3591 | |
• Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N)92 | |
• University of Washington Quality of Life Scale (UW-QoL v4)93 | |
• Patient Concerns Inventory (PCI-HN)58 | |
Late effects | • Oral rehabilitation: Liverpool Oral Rehabilitation Questionnaire (LORQ)94 |
• Trismus: Gothenburg Trismus Questionnaire (GTQ)95 | |
• Swallowing: Swallowing Quality of Life Questionnaire (SWAL-QOL)96 | |
• Xerostomia Questionnaire (XQ)97 | |
Recurrence | • Vanderbilt Head and Neck Symptom Survey (VHNSS)98 |
Palliation | • EORTC QLQ-C15-PAL99 |
• Family Assessment of Treatment at the End of life (FATE)100 | |
• Schedule for the Evaluation of Individual Quality of Life (SEIQoL)76 |
Abbreviation: HRQOL, health related quality of life; HNC, head and neck cancer.